Acadian Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-739
| Closed | -$39K | – | 2431 |
|
|
2020
Q3 | $39K | Sell |
739
-41,290
| -98% | -$2.55M | ﹤0.01% | 1922 |
|
|
2020
Q2 | $2.58M | Buy |
+42,029
| New | +$2.43M | 0.01% | 667 |
|
|
2019
Q4 | – | Sell |
-113,980
| Closed | -$6.1M | – | 2154 |
|
|
2019
Q3 | $6.1M | Buy |
+113,980
| New | +$6.64M | 0.03% | 426 |
|
|
2019
Q2 | – | Sell |
-144,630
| Closed | -$9.02M | – | 2147 |
|
|
2019
Q1 | $9.02M | Sell |
144,630
-2,678
| -2% | -$177K | 0.04% | 323 |
|
|
2018
Q4 | $8.93M | Buy |
147,308
+10,740
| +8% | +$642K | 0.04% | 282 |
|
|
2018
Q3 | $7.99M | Buy |
136,568
+25,634
| +23% | +$1.31M | 0.03% | 311 |
|
|
2018
Q2 | $4.98M | Buy |
110,934
+1,806
| +2% | +$77.7K | 0.02% | 387 |
|
|
2018
Q1 | $4.84M | Sell |
109,128
-3,106
| -3% | -$130K | 0.02% | 406 |
|
|
2017
Q4 | $4.86M | Sell |
112,234
-13,986
| -11% | -$629K | 0.02% | 383 |
|
|
2017
Q3 | $5.87M | Sell |
126,220
-38,718
| -23% | -$1.85M | 0.03% | 349 |
|
|
2017
Q2 | $8.17M | Sell |
164,938
-19,666
| -11% | -$1.03M | 0.04% | 315 |
|
|
2017
Q1 | $10.1M | Sell |
184,604
-6,523
| -3% | -$345K | 0.05% | 281 |
|
|
2016
Q4 | $10.6M | Sell |
191,127
-18,239
| -9% | -$877K | 0.05% | 271 |
|
|
2016
Q3 | $9.56M | Sell |
209,366
-7,129
| -3% | -$286K | 0.05% | 280 |
|
|
2016
Q2 | $8.64M | Sell |
216,495
-50,196
| -19% | -$1.84M | 0.04% | 279 |
|
|
2016
Q1 | $9.28M | Sell |
266,691
-2,024
| -0.8% | -$74.3K | 0.05% | 287 |
|
|
2015
Q4 | $11.5M | Buy |
268,715
+8,019
| +3% | +$402K | 0.06% | 274 |
|
|
2015
Q3 | $11.4M | Buy |
260,696
+64,579
| +33% | +$3.49M | 0.06% | 270 |
|
|
2015
Q2 | $10.1M | Buy |
196,117
+16,335
| +9% | +$696K | 0.05% | 290 |
|
|
2015
Q1 | $7.04M | Buy |
179,782
+25,356
| +16% | +$994K | 0.03% | 331 |
|
|
2014
Q4 | $5.96M | Buy |
154,426
+60,586
| +65% | +$2.31M | 0.03% | 378 |
|
|
2014
Q3 | $3.31M | Buy |
93,840
+30,034
| +47% | +$882K | 0.02% | 419 |
|
|
2014
Q2 | $1.72M | Buy |
63,806
+32,985
| +107% | +$859K | 0.01% | 523 |
|
|
2014
Q1 | $798K | Buy |
30,821
+10,584
| +52% | +$254K | ﹤0.01% | 601 |
|
|
2013
Q4 | $438K | Buy |
20,237
+3,814
| +23% | +$78.1K | ﹤0.01% | 708 |
|
|
2013
Q3 | $320K | Buy |
+16,423
| New | +$291K | ﹤0.01% | 699 |
|
Other funds holding BSTC
Acadian Asset Management's BSTC Position: Q4 2020 in Review
Acadian Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 739 shares — an estimated $39K sold.
Acadian Asset Management first reported a position in BSTC in Q3 2013 and held it in 26 quarters. The position peaked at $11.5M in Q4 2015. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Acadian Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Acadian Asset Management sold 739 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $39K.
- Acadian Asset Management first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 26 quarters.
- Acadian Asset Management's BioSpecifics Technologies Corp. position peaked at $11.5M in Q4 2015.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Acadian Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.